Overall, the data suggest that the oncogenesis of high-risk ALL involves low levels of ARID5B expression, and that low expression of ARID5B and PHF2, along with haploinsufficiency of Ikaros, represents a high-risk subgroup of ALL. Here, PHF2 is linked to acute lymphoblastic leukemia.